Another report of a greedy drug CEO hated by his community for enriching himself off the government and sick.
View original post 539 more words
If interested, read this Chicago Tribune article of February 19, 2016 about who really pays when Marathon Pharmaceutical makes a statement that a patient only pays $20 instead of $89,000 for their drug.
Then decide if the Orphan Drug Act needs to be amended.
No comments:
Post a Comment